Continued Improvement of Signs and Symptoms in Patients with Active Psoriatic Arthritis: Week 52 Results of a Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study.

被引：0
|
作者：
Kavanaugh, Arthur [1 ]
McInnes, Iain B. [2 ]
Gottlieb, Alice B. [3 ]
Puig, Lluis [4 ]
Rahman, Proton [5 ]
Ritchlin, Christopher T. [6 ]
Li, Shu [7 ]
Wang, Yuhua [7 ]
Doyle, Mittie K. [7 ]
Mendelsohn, Alan M. [7 ]
机构：
[1] UCSD Sch Med, La Jolla, CA USA
[2] Univ Glasgow, Glasgow, Lanark, Scotland
[3] Tufts Med Ctr, Boston, MA USA
[4] Univ Autonoma Barcelona, Barcelona, Spain
[5] Mem Univ Newfoundland, St John, NF, Canada
[6] Univ Rochester, Med Ctr, Rochester, NY 14642 USA
[7] Janssen Res & Dev LLC, Spring House, PA USA
来源：
ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
L4
引用
收藏
页码：4168 / 4168
页数：1
相关论文
共 50 条
  • [41] Anti-Interleukin 17A Monoclonal Antibody Secukinumab Reduces Signs and Symptoms of Psoriatic Arthritis in a 24-Week Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial
    McInnes, I.
    Sieper, J.
    Braun, J.
    Emery, Paul
    van der Heijde, D.
    Isaacs, J.
    Dahmen, G.
    Wollenhaupt, J.
    Schulze-Koops, H.
    Gsteiger, S.
    Bertolino, A.
    Hueber, W.
    Tak, P. P.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S306 - S306
  • [42] Secukinumab Shows Substantial Improvement In Both Psoriasis Symptoms and Physical Functioning In Moderate-To-Severe Plaque Psoriasis Patients With Psoriatic Arthritis: A Subanalysis Of a Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study
    Gottlieb, Alice B.
    Sigurgeirsson, Bardur
    Blauvelt, Andrew
    Mpfofu, Shephard
    Martin, Ruvie
    Papavassilis, Charis
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S136 - S137
  • [43] SECUKINUMAB INHIBITS RADIOGRAPHIC PROGRESSION IN PATIENTS WITH PSORIATIC ARTHRITIS: DATA FROM A PHASE 3 RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY (FUTURE 1)
    Van der Heijde, D.
    Landewe, R.
    Mease, P.
    McInnes, I. B.
    Conaghan, P. G.
    Pricop, L.
    Ligozio, G.
    Richards, H.
    Mpofu, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 347 - 348
  • [44] Apremilast in Patients With Active Rheumatoid Arthritis: A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study
    Genovese, Mark C.
    Jarosova, Katerina
    Cieslak, Dorota
    Alper, Jeffrey
    Kivitz, Alan
    Hough, Douglas R.
    Maes, Peter
    Pineda, Lilia
    Chen, Mindy
    Zaidi, Farrukh
    ARTHRITIS & RHEUMATOLOGY, 2015, 67 (07) : 1703 - 1710
  • [45] The effect of guselkumab on inhibiting radiographic progression in patients with active psoriatic arthritis: study protocol for APEX, a Phase 3b, multicenter, randomized, double-blind, placebo-controlled trial
    Ritchlin, Christopher T.
    Coates, Laura C.
    Mease, Philip J.
    van der Heijde, Desiree
    Song, Jiao
    Jiang, Yusang
    Shawi, May
    Kollmeier, Alexa P.
    Rahman, Proton
    TRIALS, 2023, 24 (01)
  • [46] The effect of guselkumab on inhibiting radiographic progression in patients with active psoriatic arthritis: study protocol for APEX, a Phase 3b, multicenter, randomized, double-blind, placebo-controlled trial
    Christopher T. Ritchlin
    Laura C. Coates
    Philip J. Mease
    Désirée van der Heijde
    Jiao Song
    Yusang Jiang
    May Shawi
    Alexa P. Kollmeier
    Proton Rahman
    Trials, 24
  • [47] Effects of inflammatory suppression with onercept on vascular risk factors in psoriatic arthritis: Double-blind placebo-controlled study.
    Sattar, N
    Crompton, P
    Cherry, L
    Lowe, G
    McInnes, IB
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S561 - S561
  • [48] Radiographic Progression Inhibition with Intravenous Golimumab in Psoriatic Arthritis: Week 24 Results of a Phase III, Randomized, Double-blind, Placebo-controlled Trial
    Kavanaugh, Arthur
    Husni, M. Elaine
    Harrison, Diane D.
    Kim, Lilianne
    Lo, Kim Hung
    Noonan, Lenore
    Hsia, Elizabeth C.
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (06) : 595 - 602
  • [49] Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double- blind randomised placebo- controlled study (RAPID-PsA)
    Mease, P. J.
    Fleischmann, R.
    Deodhar, A. A.
    Wollenhaupt, J.
    Khraishi, M.
    Kielar, D.
    Woltering, F.
    Stach, C.
    Hoepken, B.
    Arledge, T.
    van der Heijde, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (01) : 48 - 55
  • [50] Secukinumab is effective in reducing dactylitis and enthesitis using multiple measures in patients with psoriatic arthritis: Results of a phase 3 randomized, multicenter, double-blind, placebo-controlled study (FUTURE 2)
    Mease, P.
    Kirkham, B.
    McInnes, I. B.
    Kremer, J.
    Kandala, S.
    Pricop, L.
    Mpofu, S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S30 - S30
12345